Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches ; volume:10 ; number:1 ; day:4 ; month:5 ; year:2013 ; pages:1-14 ; date:12.2013
Virology journal ; 10, Heft 1 (4.5.2013), 1-14, 12.2013
- Creator
-
Thompson, Christine M.
- Contributor
-
Petiot, Emma
Lennaertz, Alexandre
Henry, Olivier
Kamen, Amine A.
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-10-141
- URN
-
urn:nbn:de:1111-2016050111384
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Thompson, Christine M.
- Petiot, Emma
- Lennaertz, Alexandre
- Henry, Olivier
- Kamen, Amine A.
- SpringerLink (Online service)
Other Objects (12)
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
Virus-like particle based vaccines : stabilization by freeze-drying and development of sustained release devices
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
Virus-like particle based vaccines : stabilization by freeze-drying and development of sustained release devices
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea